DIN 02408813 — CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE 2 MG
CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE is a solution of Cisatracurium marketed by OMEGA LABORATORIES LIMITED. The full Cisatracurium monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02408813
- Brand name
- CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE
- Active ingredient
- Cisatracurium
- Strength
- 2 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- OMEGA LABORATORIES LIMITED
- Health Canada status
- MARKETED
- Drug class
- Non-depolarizing neuromuscular blocking agent (skeletal muscle relaxant)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Cisatracurium products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02563266 | CISATRACURIUM BESYLATE INJECTION USP MULTI-DOSE | 2 MG | SOLUTION | STERIMAX INC | MARKETED |
| 02408805 | CISATRACURIUM OMEGA SINGLE DOSE | 2 MG | SOLUTION | OMEGA LABORATORIES LIMITED | DORMANT |